Pseudo-rearrangement of the MLL gene at chromosome 11q23: A cautionary note on genotype analysis of leukaemia patients

Journal of Clinical Pathology - Molecular Pathology

Volumn 51, Issue 2, 1998, Pages 85-89

  Stanulla, M ^a   Schunemann H J ^b   Thandla, S ^a   Brecher, M L ^a   Aplan, P D ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Leukaemia; Misclassification; MLL; Molecular diagnostics

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW BIOPSY; CHROMOSOME 11Q; CLINICAL ARTICLE; CONTROLLED STUDY; GENE REARRANGEMENT; GENOTYPE; HUMAN; LEUKEMOGENESIS; PRIORITY JOURNAL;

EID: 0031840578     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.51.2.85     Document Type: Article

References (29)

1. Ziemin-van der Poel S, McCabe NR, Gill HJ, et al. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 1991;88:10735-9.
2. Djabali M, Selleri L, Parry P, et al. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukemias. Nat Genet 1992;2:113-18.
3. Gu Y, Nakamura T, Alder H, et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 1992;71:701-8.
4. Tkachuk D, Kohler S, Cleary M. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 1992;71:691-700.
5. Thirman MJ, Gill HJ, Burnett RC, et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 1993;329:909-14.
6. Rubnitz JE, Behm FG, Downing JR. 11q23 rearrangements in acute leukemia. Leukemia 1996;10:74-82.
7. Hilden JM, Frestesdt JL, Kersey JH. Molecular analysis of infant acute leukemia. Leuk Lymphoma 1997;25:191-9.
8. Gill-Super HJ, McCabe NR, Thirman MJ, et al. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA topoisomerase II. Blood 1993;82:3705-11.
9. Bower M, Parry P, Gibbons B, et al. Human trithorax gene rearrangements in therapy-related acute leukemia after etoposide treatment. Leukemia 1994;8:226-9.
10. Cleary ML. A promiscuous oncogene in acute leukemia. N Engl J Med 1993;329:958-9.
11. Smith M, Bleyer A, Crist W, et al. Uniform criteria for childhood acute lymphoblastic leukemia risk classification. J Clin Oncol 1996;14:680-1.
12. Caligiuri MA, Strout MP, Gilliland DG. Molecular biology of acute myeloid leukemia. Semin Oncol 1997;24:32-44.
13. Chen C-S, Sorensen PHB, Domer PH, et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and a poor outcome. Blood 1993;81:2386-93.
14. Pui C-H, Behm FG, Downing JR, et al. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol 1994;12:909-15.
15. Sorensen PHB, Chen C-S, Smith FO, et al. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes. J Clin Invest 1994;93:429-37.
16. Taki T, Ida K, Bessho F, et al. Frequency and clinical significance of MLL gene rearrangements in infant acute leukemia. Leukemia 1996;10:1303-7.
17. Aplan PD, Chervinsky DS, Stanulla M, et al. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 1996;87: 2649-58.
18. Stanulla M, Wang J, Chervinsky DS, et al. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Mol Cell Biol 1997;17:4070-9.
19. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251-306.
20. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994;78:539-42.
21. McCabe NR, Burnett RC, Gill HJ, et al. Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations. Proc Natl Acad Sci USA 1992;89: 11794-9.
22. Berezney R, Coffey DS. Identification of a nuclear protein matrix. Biochem Biophys Res Commun 1974;60:1410-19.
23. Mircovich J, Mirault ME, Laemmli UK. Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold. Cell 1984;39:23-32.
24. Oberhammer FA, Wilson JW, Dive C, et al. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in absence of internucleosomal fragmentation. EMBO J 1993;12:3679-84.
25. Bortner CD, Oldenburg NBE, Cidlowski JA. The role of DNA fragmentation in apoptosis. Trends Cell Biol 1995;5: 21-6.
26. Strissel-Broeker PL, Gill-Super H, Thirman MJ, et al. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute myeloid leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II binding sites. Blood 1996;87:1912-22.
27. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993;81: 2237-51.
28. Mrózek K, Heinonen K, de la Chapelle A, et al. Clinical significance of cytogenetics in acute myeloid leukemia. Semin Oncol 1997;24:17-31.
29. Macintyre E, Bourquelot P, Leboeuf D, et al. MLL cleavage occurs in approximately 5% of de novo acute myeloid leukemia, including in patients analyzed before treatment induction. Blood 1997;89:2224-6.